The Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) and Treatment with Ruxolitinib on Survival in Patients with Myelofibrosis

Autor: Jaekel, Nadja *, Wang, Song-Yau *, Krahl, Rainer *, Hubert, Karolin *, Schulze, Susann *, Stengel, Rayk *, Schneider, Melanie *, Roskos, Martin *, Niederwieser, Dietger, Al-Ali, Haifa Kathrin *
Zdroj: In Blood 3 December 2015 126(23):2014-2014
Databáze: ScienceDirect